Related Experiment Video

Updated: Mar 28, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

8.1K

Construction and analysis of three networks of genes and microRNAs in adenocarcinoma

Jiahui Ning1, Xiaoxin Guo1, Ning Wang1

  • 1Department of Computer Science and Technology, Jilin University, Changchun, Jilin 130012, P.R. China ; Key Laboratory of Symbol Computation and Knowledge Engineering of The Ministry of Education, Jilin University, Changchun, Jilin 130012, P.R. China.

Oncology Letters
|January 2, 2016
PubMed

Insights

This study maps gene and microRNA networks in adenocarcinoma, identifying key transcription factors like TP53. These findings reveal regulatory pathways, aiding future gene therapy research for adenocarcinoma treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Bioinformatics

Background:

  • Adenocarcinoma poses a significant health threat, with extensive but fragmented data on its associated genes and microRNAs (miRNAs).
  • Previous research often focused on limited gene/miRNA sets, hindering comprehensive understanding of their complex interactions in adenocarcinoma.

Purpose of the Study:

  • To construct and analyze integrated gene and miRNA regulatory networks in adenocarcinoma.
  • To identify key transcription factors (TFs) and regulatory associations within these networks.

Main Methods:

  • Construction of three distinct networks: differentially-expressed, associated, and global, incorporating TFs, miRNAs, and their target/host genes.
  • Comparative analysis of network similarities and differences.
  • Identification of upstream and downstream regulatory elements for differentially-expressed genes and miRNAs.

Main Results:

  • Identification of three significant TFs (TP53, PTEN, SMAD4) regulating differentially-expressed genes and miRNAs in adenocarcinoma.
  • Discovery of crucial regulatory associations, including self-regulation between TFs and miRNAs.
  • Elucidation of gene-miRNA regulatory relationships through upstream and downstream element mapping.

Conclusions:

  • The study provides a comprehensive view of adenocarcinoma pathogenesis by revealing intricate gene and miRNA regulatory networks.
  • Identified TFs and regulatory pathways offer a theoretical foundation for developing novel gene therapy strategies for adenocarcinoma.
Keywords:
adenocarcinomahost genesmicroRNAtarget genesthree networkstranscription factors

More Related Videos

miRNA Expression Analyses in Prostate Cancer Clinical Tissues11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

11.3K
Clinicopathological Analysis of miRNA Expression in Breast Cancer Tissues by Using miRNA In Situ Hybridization06:01

Clinicopathological Analysis of miRNA Expression in Breast Cancer Tissues by Using miRNA In Situ Hybridization

Published on: June 7, 2016

7.2K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K